Lopressor and Ibrutinib drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lopressor (metoprolol tartrate) and Ibrutinib (ibrutinib). Common drug interactions include dyspnoea among females and oesophageal squamous cell carcinoma among males.

The phase IV clinical study analyzes what interactions people have when they take Lopressor and Ibrutinib. It is created by eHealthMe based on reports of 27 people who take the same drugs from the FDA, and is updated regularly.

What is Lopressor?

Lopressor has active ingredients of metoprolol tartrate. It is often used in high blood pressure. eHealthMe is studying from 33,152 Lopressor users. Check the latest studies of Lopressor.

What is Ibrutinib?

Ibrutinib has active ingredients of ibrutinib. eHealthMe is studying from 13,529 Ibrutinib users. Check the latest studies of Ibrutinib.

On Jul, 16, 2026

27 people who take Lopressor and Ibrutinib together, and have interactions are studied.

Lopressor and Ibrutinib drug interactions.

What are the common drug interactions of Lopressor and Ibrutinib, by gender? *:

female:

Dyspnoea (difficult or laboured respiration)
Diarrhoea
Palpitations (feelings or sensations that your heart is pounding or racing)
Supraventricular extrasystoles (premature electrical impulse in the heart, generated above the level of the ventricle)
Chest discomfort
Dermatitis allergic (inflammation of the skin due allergic reaction)
Oedema peripheral (superficial swelling)
Back pain
Colitis (inflammation of colon)
Bladder disorder

male:

Oesophageal squamous cell carcinoma (cancer that begins in flat cells lining the oesophagus)
Pneumonia bacterial (pneumonia associated with bacterial infection)
Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
Systemic inflammatory response syndrome (an inflammatory state affecting the whole body, frequently a response of the immune system to infection)
Pericardial effusion (fluid around the heart)
Pleural effusion (water on the lungs)
Pneumonia
Anaemia (lack of blood)
Back pain
Death

What are the common drug interactions of Lopressor and Ibrutinib, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Dyspnoea (difficult or laboured respiration)
Diarrhoea
Respiratory failure (inadequate gas exchange by the respiratory system)
Respiratory tract infection
Septic shock (shock due to blood infection)
Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
Mental status changes (general changes in brain function, such as confusion, amnesia (memory loss), loss of alertness, loss of orientation)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Sepsis (a severe blood infection that can lead to organ failure and death)
Sinusitis (inflammation of sinus)

What are the existing conditions these people have? *

Chronic Lymphocytic Leukaemia (cancer in which the bone marrow makes too many lymphocytes (a type of white blood cell)): 22 people, 81.48%
Dyslipidaemia (abnormal amount of lipids): 5 people, 18.52%
Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 18.52%
Thrombosis (formation of a blood clot inside a blood vessel): 3 people, 11.11%
Sacroiliitis (an inflammation of the sacroiliac joint): 2 people, 7.41%
Non-Hodgkin's Lymphoma (malignant (cancer) cells form in the lymph system): 2 people, 7.41%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 2 people, 7.41%
Enlarged Prostate: 2 people, 7.41%
Diarrhea: 2 people, 7.41%
Chronic Lymphocytic Leukaemia Recurrent (repeated cancer of blood cells known as lymphocytes): 2 people, 7.41%

* Approximation only. Some reports may have incomplete information.

Do you take Lopressor and Ibrutinib?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously